Ab&B Bio-Tech's (HKG:2627) Chief Financial Officer Li Runxiang resigned effective Wednesday due to work adjustment, a same-day bourse filing showed.
The biotech company, on the same day, named Wu Jingyun as its new CFO, a Wednesday bourse filing showed.
Wu has also been nominated as an executive Director, subject to shareholder approval at the company's general meeting.
Trading in the company's shares, which was suspended April 1, remains suspended.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.